A

Adaptive Biotechnologies Corp
D

ADPT

9.82500
USD
2.50
(34.04%)
مغلق
حجم التداول
903,497
الربح لكل سهم
-1
العائد الربحي
-
P/E
-9
حجم السوق
1,492,581,794
أصول ذات صلة
ABBV
ABBV
5.160
(2.67%)
198.440 USD
AMGN
AMGN
-2.15
(-0.76%)
281.20 USD
BIIB
BIIB
2.500
(2.07%)
123.460 USD
GILD
GILD
0.420
(0.41%)
103.660 USD
MRK
MRK
-0.090
(-0.11%)
83.160 USD
PFE
PFE
0.065
(0.27%)
24.185 USD
REGN
REGN
15.98
(2.71%)
606.12 USD
SNY
SNY
1.360
(2.51%)
55.470 USD
المزيد
الأخبار المقالات

العنوان: Adaptive Biotechnologies Corp

القطاع: Healthcare
الصناعة: Biotechnology
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product,clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is alsoavailable as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).